Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Clinical effectiveness of repetitve transcranial magnetic stimulation (rTMS) as an adjunctive therapy in depression - a catchment area-based randomised controlled trial
ISRCTN ISRCTN70121208
ClinicalTrials.gov identifier
Public title Clinical effectiveness of repetitve transcranial magnetic stimulation (rTMS) as an adjunctive therapy in depression - a catchment area-based randomised controlled trial
Scientific title
Acronym TMSplus Trial
Serial number at source N/A
Study hypothesis TMS can be used as an adjunctive treatment for depression
Ethics approval Institute of Psychiatry Ethical Committee (Research), ref: 251/00
Study design Parallel group randomised placebo-controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Major depressive disorder
Participants - inclusion criteria Over 18 years old, right-handed and have a diagnosis of major depressive disorder (DSM-IV)
Participants - exclusion criteria 1. History of seizures
2. Head injury with loss of consciousness
3. Brain surgery
4. Presence of metallic implants
5. Evidence of dementia or other Axis 1 diagnosis
6. Substance misuse within the previous six months
7. Previous treatment with rTMS
8. Inability to provide informed consent
Anticipated start date 01/03/2002
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants 54
Interventions Real or sham repetitve transcranial magnetic stimulation (rTMS)
Primary outcome measure(s) Hamilton Rating Scale for Depression (HDRS)
Secondary outcome measure(s) Clinical:
1. Beck Depression Inventory-II (BDI-II)
2. Visual Analogue Mood Scales (VAMS)
3. Brief Psychiatric Rating Scale (BPRS)

Subjective side-effects:
1. Modified Columbia ECT Subjective Side Effects Schedule (CSSES)

Cognition:
1. CAMCOG, digit-span test
2. Digit symbols modalities test
3. Grooved pegboard test

Quality of life:
SF-36 questionnaire

Economic:
Client Service Receipt Inventory (CSRI)
Sources of funding Guy's & St Thomas' Charitable Foundation (R001126) (UK)
Trial website
Publications
Contact name Dr  Declan  McLoughlin
  Address Section of Old Age Psychiatry PO70
Institute of Psychiatry
De Crespigny Park
  City/town London
  Zip/Postcode SE5 8AF
  Country United Kingdom
  Tel +44 (0)20 78480547
  Email d.mcloughlin@iop.kcl.ac.uk
Sponsor South London and Maudsley NHS Trust (UK)
  Address Denmark Hill
London
SE5 8AZ
  City/town London
  Zip/Postcode SE5 8AZ
  Country United Kingdom
  Sponsor website: http://www.slam.nhs.uk/
Date applied 07/02/2007
Last edited 05/03/2007
Date ISRCTN assigned 05/03/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central